2nd Quarter - Report

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CVS HEALTH

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to COVID-19 testing and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials; H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022

LobbyistCovered position, as disclosed
THOMAS DASCHLE Former United States Senator
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 7213 (117th), H.R. 5376 (117th), S. 4293 (117th)

Medicare/Medicaid MMM

Policy and reimbursement changes to the MA program

LobbyistCovered position, as disclosed
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

S.1260 - United States Innovation and Competition Act of 2021, provisions relating to research and development tax deductibility and the sale of online goods; H.R.4521 - United States Innovation and Competition Act of 2021, provisions relating to provisions relating to research and development tax deductibility and the sale of online goods.

LobbyistCovered position, as disclosed
TIFFANI VIVIENNE WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4521 (117th), S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.